Who may benefit from an increased gonadotropin dosing in predicted poor responders undergoing IVF/ICSI? A secondary analysis assessing treatment selection markers of a randomized trial
Ginecologia e ObstetríciaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- European journal of obstetrics, gynecology, and reproductive biology
- Publicado em
- 11 out 2023
- Citações
- 7
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Who may benefit from an increased gonadotropin dosing in predicted poor responders undergoing IVF/ICSI? A secondary analysis assessing treatment selection markers of a randomized trial
Xitong Liu, Wentao Li, Ben W Mol, Wen Wen, Tao Wang, Li Tian, Na Li, Ting Sun, Ting Wang, Hanying Zhou et al.
Descritores MeSH
- Fertilization in Vitro
- Sperm Injections, Intracytoplasmic
- Gonadotropins
- Humans
- Ovulation Induction
- Pregnancy
- Pregnancy Rate
- Follicle Stimulating Hormone, Human
- Female
- Live Birth
Veja também
Estudos relacionados
- Hormônio folículo-estimulante recombinante (rFSH) versus outras gonadotropinas recombinantes ou urinárias para estimulação ovariana em ciclos de tecnologia reprodutiva assistida
- Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
- Effect of increased gonadotropin dosing on maternal and neonatal outcomes in predicted poor responders undergoing IVF: follow-up of a randomized trial
- Comparative Effectiveness of Recombinant Human Follicle-Stimulating Hormone:Recombinant Human Luteinizing Hormone in a 2:1 Ratio versus Highly Purified Human Menopausal Gonadotropin Alone in Ovarian Stimulation for Medically Assisted Reproduction Treatment Using in vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis